You are here

Clinical Trials: Trauma

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, December 4, 2020 - 12:00
Condition:   Brachial Plexus Neuropathies
Interventions:   Procedure: Nerve transfer procedure;   Procedure: Nerve transfer with HAM-AdMSC composite wrapping
Sponsor:   Dr. Soetomo General Hospital
Posted: Tuesday, November 17, 2020 - 12:00
Condition:   Ischemic Stroke
Intervention:   Biological: Neural Stem Cells
Sponsor:   Gary Steinberg
Not yet recruiting
Posted: Wednesday, November 11, 2020 - 12:00
Condition:   COVID19 ARDS
Interventions:   Biological: Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells;   Biological: Placebo
Sponsor:   Central Hospital, Nancy, France
Not yet recruiting
Posted: Tuesday, November 3, 2020 - 12:00
Condition:   Crohn's Fistula
Interventions:   Biological: ASC(Autologous Adipose-derived Mesenchymal Stem Cells);   Drug: Fibringlue
Sponsor:   Anterogen Co., Ltd.
Posted: Monday, October 26, 2020 - 12:00
Condition:   Acute Respiratory Distress Syndrome
Interventions:   Biological: low dose hMSC-Exos;   Biological: medium dose hMSC-Exos;   Biological: high dose hMSC-Exos;   Biological: Dosage 1of hMSC-Exos;   Biological: Dosage 2 of hMSC-Exos;   Biological: No hMSC-derived exosomes
Sponsors:   Ruijin Hospital;   Cellular Biomedicine Group Ltd.
Not yet recruiting
Posted: Monday, October 19, 2020 - 12:00
Conditions:   Chronic Kidney Diseases;   Calciphylaxis;   Calcific Uremic Arteriolopathy;   Treatment
Intervention:   Other: Human amniotic mesenchymal stem cells
Sponsor:   Ningning Wang
Posted: Friday, October 9, 2020 - 12:00
Condition:   Respiratory Distress Syndrome, Adult
Intervention:   Drug: agenT-797
Sponsor:   AgenTus Therapeutics, Inc.
Posted: Tuesday, September 29, 2020 - 12:00
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Vehicle Sheet
Sponsor:   Anterogen Co., Ltd.
Posted: Monday, September 21, 2020 - 12:00
Condition:   Burn Scar
Interventions:   Procedure: platelet rich plasma injection in post burn facial scar;   Procedure: fat injection in post burn facial scar
Sponsor:   Assiut University
Not yet recruiting
Posted: Friday, September 4, 2020 - 12:00
Condition:   MSCs Derived Pleiotropic Factors in Treating Poorly Healed Wounds
Intervention:   Biological: The pleiotropic factor derived from mesenchymal stem cells
Sponsors:   Chinese PLA General Hospital;   Gansu Provincial Maternity and Child-Care Hospital
Not yet recruiting